CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-04-20 | MCNAB JAMES R Director | Sale | −22,541 | $2.66 | $60K | 1,057,147 |
| 2017-04-20 | MCNAB JAMES R Director | Sale | −22,541 | $2.66 | $60K | 1,357,147 |
| 2017-02-28 | Martell Robert Director | Grant or award · Non-qualified stock option | +120,000 | 120,000 | ||
| 2017-02-28 | MCNAB JAMES R Director | Grant or award · Non-qualified stock option | +120,000 | 120,000 | ||
| 2017-02-28 | KAITIN KENNETH I Director | Grant or award · Non-qualified stock option | +120,000 | 120,000 | ||
| 2017-02-28 | Pienta Kenneth Director | Grant or award · Non-qualified stock option | +120,000 | 120,000 | ||
| 2017-02-28 | GREENACRE MARTYN D Director | Grant or award · Non-qualified stock option | +120,000 | 120,000 | ||
| 2017-02-28 | Rubin Marc Director | Grant or award · Non-qualified stock option | +120,000 | 120,000 | ||
| 2017-02-28 | Kunkel Lori Anne Director | Grant or award · Non-qualified stock option | +120,000 | 120,000 | ||
| 2017-02-14 | Mohindru Mani Chief Strategy Officer | Grant or award · Employee stock option (right to buy) | +424,000 | 424,000 | ||
| 2017-02-14 | Tuck David Chief Medical Officer | Grant or award · Employee stock option (right to buy) | +534,000 | 534,000 | ||
| 2017-02-14 | Fattaey Ali Ph.D. President & CEO | Grant or award · Employee stock option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2016-11-11 | Kunkel Lori Anne Director | Grant or award · Non-qualified stock option | +25,000 | 25,000 | ||
| 2016-09-07 | Aurigene Discovery Technologies Ltd 10% owner | Purchase | +10,208,333 | $2.40 | $24.5M | 27,328,464 |
| 2016-05-27 | GREENACRE MARTYN D Director | Option exercise | +5,000 | $1.67 | $8K | 40,183 |
| 2016-05-27 | GREENACRE MARTYN D Director | Sale | −5,000 | $1.69 | $8K | 35,183 |
| 2016-05-27 | GREENACRE MARTYN D Director | Option exercise | +10,000 | $1.67 | $17K | 45,183 |
| 2016-05-27 | GREENACRE MARTYN D Director | Sale | −10,000 | $1.69 | $17K | 35,183 |
| 2016-05-27 | GREENACRE MARTYN D Director | Option exercise · Non-qualified stock option (right to buy) | −5,000 | $1.67 | $8K | 0 |
| 2016-05-27 | GREENACRE MARTYN D Director | Option exercise · Non-qualified stock option (right to buy) | −10,000 | $1.67 | $17K | 0 |
Page 9 of 17 · 326 trades